Previous Article | Next Article ![]()
Molecular and Cellular Biology, November 1999, p. 7688-7696, Vol. 19, No. 11
Department of Immunology, The Scripps
Research Institute, La Jolla, California 920371;
Department of Medicine, University of California, San Diego, La
Jolla, California 920932; and Vertex
Pharmaceuticals Inc., Cambridge, Massachusetts
021393
Received 3 March 1999/Returned for modification 8 April
1999/Accepted 10 August 1999
Members of the NF-
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
RelB Modulation of I
B
Stability as a Mechanism of
Transcription Suppression of Interleukin-1
(IL-1
), IL-1
, and
Tumor Necrosis Factor Alpha in Fibroblasts
B/RelB family of transcription factors play
important roles in the regulation of inflammatory and immune responses.
RelB, a member of this family, has been characterized as a
transcription activator and is involved in the constitutive NF-
B
activity in lymphoid tissues. However, in a previous study we observed
an overexpression of chemokines in RelB-deficient fibroblasts. Here we
show that RelB is an important transcription suppressor in fibroblasts
which limits the expression of proinflammatory mediators and may exert
its function by modulating the stability of I
B
protein.
Fibroblasts from relb
/
mice overexpress
interleukin-1
(IL-1
), IL-1
, and tumor necrosis factor alpha in
response to lipopolysaccharide (LPS) stimulation. These cells have an
augmented and prolonged LPS-inducible IKK activity and an accelerated
degradation which results in a diminished level of I
B
protein,
despite an upregulated I
B
mRNA expression. Consequently, NF-
B
activity was augmented and postinduction repression of NF-
B activity
was impaired in these cells. The increased
B-binding activity and
cytokine overexpression was suppressed by introducing RelB cDNA or a
dominant negative I
B
into relb
/
fibroblasts. Our findings suggest a novel transcription suppression function of RelB in fibroblasts.
*
Corresponding author. Mailing address: Department of
Immunology, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Phone: (858) 784-8262. Fax: (858) 784-8558. E-mail:
llfimm{at}scripps.edu.
Publication 12172-IMM from the Department of Immunology, The
Scripps Research Institute, La Jolla, Calif.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|